Product Information

NORG-EE 0.18-0.215-0.25/0.035 is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1234 per EA under NDC 68462056529. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Jun 17, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NORG-EE 0.18-0.215-0.25/0.035

Norgestimate and Ethinyl Estradiol
$0.1234per EA

NDC

68462056529

Classification

Generic

Dosage Form

KIT

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA200494

FDA Approved

6/17/2011

TE Code

AB

On Market Since

6/17/2011

Price Statistics

The NADAC for NORG-EE 0.18-0.215-0.25/0.035 has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 64.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1234 per EA
All-time high$0.3811 (Apr 16, 2014)
All-time low$0.1072 (Jul 17, 2024)
52-week high$0.1332
52-week low$0.1234
Median price$0.1945
Average price$0.2167
Largest weekly change-19.9% (Jul 17, 2024)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-2.4%

3M

-2.7%

6M

-7.1%

1Y

-9.4%

3Y

-9.2%

5Y

-33.2%

All

-64.3%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NORG-EE 0.18-0.215-0.25/0.035?

The current National Average Drug Acquisition Cost (NADAC) for NORG-EE 0.18-0.215-0.25/0.035, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1234 per EA (NDC 68462056529), effective Nov 11, 2026.

How has the price of NORG-EE 0.18-0.215-0.25/0.035 changed over time?

Over the history we have for it, the NADAC for NORG-EE 0.18-0.215-0.25/0.035 has declined 64.3%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NORG-EE 0.18-0.215-0.25/0.035?

Since Nov 28, 2013, the NADAC for NORG-EE 0.18-0.215-0.25/0.035 has ranged from a low of $0.1072 (Jul 17, 2024) to a high of $0.3811 (Apr 16, 2014), with a median of $0.1945 per EA.

Are there cheaper alternatives to NORG-EE 0.18-0.215-0.25/0.035?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRI-VYLIBRA LO TABLET, is $0.1085 per EA — about 12% below NORG-EE 0.18-0.215-0.25/0.035.

Who manufactures NORG-EE 0.18-0.215-0.25/0.035?

NORG-EE 0.18-0.215-0.25/0.035 (NDC 68462056529) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.